ClinicalTrials.Veeva

Menu

Non-Interventional Study In Patients With Ocular Hypertension And Open Angle Glaucoma Treated With Xalatan And Xalacom (XCHANGE)

Viatris logo

Viatris

Status

Completed

Conditions

Glaucoma
Ocular Hypertension

Treatments

Other: no intervention

Study type

Observational

Funder types

Industry

Identifiers

NCT01012245
A6111100, 912-OPT-0091-131
912-OPT-0091-131

Details and patient eligibility

About

Non-interventional study to obtain real life data from the treatment with Xalatan and Xalacom in Germany and to assess the long-term efficacy and tolerability under routine conditions. Data were entered into an electronic case report form.

Enrollment

28,812 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  • patients with ocular hypertension or glaucoma, defined by SmPC

Exclusion criteria

  • defined by SmPC

Trial design

28,812 participants in 1 patient group

patients with glaucoma and ocular hypertension
Treatment:
Other: no intervention

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems